Product Images Metoclopramide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Metoclopramide NDC 51662-1288 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a drug package containing a single-use vial with 2 mL of Metoclopramide Inj., USP B. The National Drug Code of the product is 0409-3414-18. The drug has a concentration of 10 mg/2 mL (5 mg/mL) and is intended only for prescription use for intramuscular or intravenous administration. The manufacturer of the drug is Hospira and the drug code is RL-5011. The address of the manufacturer is Lake Forest, IL 60045 USA.*
Metoclopramide is a medication that can cause Tardive Dyskinesia, a serious and irreversible movement disorder. The risk of Tardive Dyskinesia increases with the duration of treatment and the total cumulative dose. If signs or symptoms of Tardive Dyskinesia appear, the medication should be discontinued, as there is no known treatment for this condition. Treatment with Metoclopramide for more than 12 weeks should be avoided, except in rare cases where the benefits outweigh the risk. (Note: has split some words and sentences, but the meaning is clear.)*
This is a description of a drug's parameters. The drug has a volume of distribution (vd) of approximately 3.5 liters per kilogram. The plasma protein binding of the drug is around 30%. The drug has a half-life of 5 hours and 6 minutes. Its oral bioavailability is 80% with a variability of 15.5%.*
This appears to be a table of pharmacokinetic data for two different doses of a drug administered by IV. The table shows information such as the dose, reference dose, route of administration, peak concentration (Cmax), and the time it takes to reach maximum concentration (hr). There are also values for clearance and volume of distribution (Vd). However, the table is incomplete and some values are not clear, so it is difficult to determine much more about the drug or its effects without additional information.*
This text is describing the unit of sale and concentration for a certain medication. The NDC (National Drug Code) number is 0409-3414-01 and the medication is available in a concentration of 10 mg/2 mL.*
This appears to be a chemical formula with molecular weight information. Without more context or knowledge of chemistry, it is difficult to provide a more specific or useful description.*
This text describes a label for a 2mL vial that will be marked with variable data in black on a white background using a 6 point B Medium font (minimum 4.5 point). The label will also include a vertical barcode on the right side, without a required quiet zone, and will not include human readable information except for the Canadian market. The unwind direction for the label is #4.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.